An open-label trial of consensus interferon 15 μg in the treatment of Chinese patients with chronic hepatitis C

Hepatology Research

Volumn 19, Issue 3, 2001, Pages 284-293

  Hwang, Shinn Jang ^a   Lee, Shou Dong ^a   Chu, Chen Wei ^a   Lu, Rei Hwa ^a   Chang, Full Young ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chronic hepatitis C; Consensus interferon; Hepatitis C virus RNA; Open label study

Indexed keywords

ALANINE AMINOTRANSFERASE; CONSENSUS INTERFERON; PLACEBO; RECOMBINANT INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HAIR LOSS; HEADACHE; HEPATITIS C; HUMAN; INJECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT; TAIWAN; THROMBOCYTOPENIA; VIROLOGY; WEIGHT REDUCTION;

EID: 0035081467     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00110-8     Document Type: Article

References (30)

1. Nature history of hepatitis C
2. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis
3. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
4. Interrelationship of blood transfusion, non-A, non B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
5. Clinical outcome after transfusion-associated hepatitis C
6. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
7. Recombinant interferon interferon alfa therapy for chronic hepatitis C, a randomized, double-blind, placebo-controlled trial
8. Randomized controlled trial of recombinant interferon-α 2b in the treatment of Chinese patients with chronic hepatitis C
9. Therapy of hepatitis C; meta-analysis of interferon alfa-2b trail
10. Therapy of hepatitis C: Interferon alfa-2a trail
11. Therapy of hepatitis C: Interferon alfa-n1 trials
12. Production, characterization and biological effects of recombinant DNA derived human interferon and interferon analogs
13. The biological activity and molecular characterization of a novel synthetic interferon alpha species, consensus interferon
14. Treatment of hairy cell leukemia with granulocyte colony stimulating factor and recombinant consensus interferon or recombinant interferon alfa-2b
15. A comparison of interferon con1 with natural recombinant interferon-α: Antiviral, antiproliferative, and natural killer inducing activities
16. Consensus interferon induces peak mRNA accumulation at lower concentration than interferon-2a
17. Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trail
18. Therapy of hepatitis C: Consensus interferon trail
19. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C
20. Re-treatment of chronic hepatitis C with consensus interferon
21. Efficacy of interferon alfacon-1 daily induction therapy followed by three-times weekly therapy in patients with chronic hepatitis C virus infection with high and low viral titers
22. Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C
23. A randomized controlled clinical trail of recombinant interferon α-2b in the treatment of acute post-transfusion hepatitis C - A preliminary report
24. The 5′-terminal sequence of the hepatitis C virus genome
25. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources
26. A proposed system for the nomenclature of hepatitis C viral genotypes
27. A pilot study of combination therapy with ribavirin plus interferon alpha for interferon alpha-resistant chronic hepatitis C
28. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone
29. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
30. Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: A preliminary study